Stock Price Quote

LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin
BSE754.55-15.2 (-1.97 %)
PREV CLOSE ( ) 769.75
OPEN PRICE ( ) 766.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 16017
TODAY'S LOW / HIGH ( )752.90 772.50
52 WK LOW / HIGH ( )583.05 972.5
NSE754.85-15.05 (-1.95 %)
PREV CLOSE( ) 769.90
OPEN PRICE ( ) 772.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 754.85 (617)
VOLUME 527266
TODAY'S LOW / HIGH( ) 753.00 773.60
52 WK LOW / HIGH ( )583 972.4
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 01-03 1983
Management Info
Manju D Gupta - Chairman Nilesh Gupta - Managing Director
Registered Office

Address Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone 022 6640 2323

Email info@lupin.com

Website www.lupin.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX

NEWS

08Dec Lupin informs about allotment of ESOP
Lupin has informed that the Allotment Committee of Directors at its meet..
05Dec Lupin launches Rufinamide Tablets in U
Lupin has launched Rufinamide Tablets USP, 200 mg and 400 mg, to market..
30Nov Lupin soars on launching Formoterol Fu
Lupin is currently trading at Rs. 762.50, up by 11.65 points or 1.55% fr..
29Nov Lupin launches Formoterol Fumarate Inh
Lupin has launched Formoterol Fumarate Inhalation Solution, 20 mcg/2 mL..
29Nov Lupin shines as its Brazilian subsidia
Lupin is currently trading at Rs. 756.80, up by 23.10 points or 3.15% fr..

Financials

in Millions
QTR Sep 22 ANNUAL 22
Net Profit1486.2-1887.00000000001
Gross Profit 1728.9 -1615.30000000001
Operating Profit 3290.34261.29999999999
Net Sales 28289.6117716.7

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  20372.25 (0.81%)
M.Cap ( in Cr)43289.61
Themis Medicare (BSE)
peergroup  1124.15 (5.44%)
M.Cap ( in Cr)1034.25
Samrat Pharmachem (BSE)
peergroup  868.80 (5.00%)
M.Cap ( in Cr)268.43
Astrazeneca Pharma I (BSE)
peergroup  3374.55 (1.14%)
M.Cap ( in Cr)8436.38
Procter&Gamble Healt (BSE)
peergroup  4188.00 (0.69%)
M.Cap ( in Cr)6951.82

Shareholding Pattern

PROMOTERS 47.11%
MUTUAL FUNDS/UTI 16.44%
NON-INSTITUTION 11.45%
FI/BANKS/INSURANCE 11.1%
GOVERNMENT 0%
FII 0%

About Lupin Ltd.

Lupin Ltd. was incorporated in the year 1983. Its today's share price is 754.55. Its current market capitalisation stands at Rs 34313.96 Cr. In the latest quarter, company has reported Gross Sales of Rs. 128282.6 Cr and Total Income of Rs.119928.2 Cr. The company's management includes R V Satam, Mark D McDade, Punita Kumar Sinha, K B S Anand, Christine Mundkur, Jean-Luc Belingard, Ramesh Swaminathan, Nilesh Gupta, Manju D Gupta.

It is listed on the BSE with a BSE Code of 500257 , NSE with an NSE Symbol of LUPIN and ISIN of INE326A01037. It's Registered office is at Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East)Mumbai-400055, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Arora & Arora, BSR & Co LLP, Deloitte Haskins & Sells, Deloitte Haskins & Sells LLP, Deloittee Haskins & Sells, SS Kapoor & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)